BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34880850)

  • 1. Molecular Surveillance of Carbapenem-Resistant Gram-Negative Bacteria in Liver Transplant Candidates.
    Schultze TG; Ferstl PG; Villinger D; Hogardt M; Bechstein WO; Göttig S; Wichelhaus TA; Zeuzem S; Trebicka J; Waidmann O; Welker MW; Kempf VAJ
    Front Microbiol; 2021; 12():791574. PubMed ID: 34880850
    [No Abstract]   [Full Text] [Related]  

  • 2. Carbapenem-resistant Gram-negative bacteria - analysis of the data obtained through a mandatory reporting system in the Rhine-Main region, Germany, 2012-2015.
    Heudorf U; Büttner B; Hauri AM; Heinmüller P; Hunfeld KP; Kaase M; Kleinkauf N; Albert-Braun S; Tessmann R; Kempf VA
    GMS Hyg Infect Control; 2016; 11():Doc10. PubMed ID: 27274441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical management of cUTI, cIAI, and HABP/VABP attributable to carbapenem-resistant Gram-negative infections in Spain.
    Ferrer R; Fariñas MC; Maseda E; Salavert M; Bou G; Díaz-Regañón J; López D; Lozano V; Gómez-Ulloa D; Fenoll R; Lara N; McCann E
    Rev Esp Quimioter; 2021 Dec; 34(6):639-650. PubMed ID: 34806858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complicated carbapenem-resistant infections: a treatment pathway analysis in Italian sites.
    Durante-Mangoni E; Bertolino L; Mastroianni C; Viale P; Bassetti M; Citton R; Gómez-Ulloa D; Roset M; McCann E
    Infez Med; 2021; 29(3):434-449. PubMed ID: 35146349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bloodstream infections in children caused by carbapenem-resistant versus carbapenem-susceptible gram-negative microorganisms: Risk factors and outcome.
    Ozsurekci Y; Aykac K; Cengiz AB; Basaranoglu ST; Sancak B; Karahan S; Kara A; Ceyhan M
    Diagn Microbiol Infect Dis; 2017 Apr; 87(4):359-364. PubMed ID: 28089138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial infection pattern, pathogenic features and resistance mechanism of carbapenem-resistant Gram negative bacilli during long-term hospitalization.
    Wen S; Feng D; Lu Z; Liu J; Peters BM; Tang H; Su D; Lin YP; Yang L; Xu Z; Shirtliff ME; Chen D
    Microb Pathog; 2018 Apr; 117():356-360. PubMed ID: 29452198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-contamination of carbapenem-resistant Gram-negative bacteria between patients and the hospital environment in the first year of a newly built surgical ward.
    Boutin S; Scherrer M; Späth I; Kocer K; Heeg K; Nurjadi D
    J Hosp Infect; 2024 Feb; 144():118-127. PubMed ID: 38081456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OXA-181-Like Carbapenemases in Klebsiella pneumoniae ST14, ST15, ST23, ST48, and ST231 from Septicemic Neonates: Coexistence with NDM-5, Resistome, Transmissibility, and Genome Diversity.
    Naha S; Sands K; Mukherjee S; Saha B; Dutta S; Basu S
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33441403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prospective evaluation of risk factors and clinical influence of carbapenem resistance in children with gram-negative bacteria infection.
    Sahbudak Bal Z; Bekmezci N; Soylu M; Sen S; Avcu G; Aydemir S; Vardar F
    Am J Infect Control; 2018 Feb; 46(2):147-153. PubMed ID: 28982610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of diverse carbapenem and multidrug resistance genes and high-risk strain types among carbapenem non-susceptible clinical isolates of target gram-negative bacteria in Kenya.
    Musila L; Kyany'a C; Maybank R; Stam J; Oundo V; Sang W
    PLoS One; 2021; 16(2):e0246937. PubMed ID: 33617559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
    Katchanov J; Asar L; Klupp EM; Both A; Rothe C; König C; Rohde H; Kluge S; Maurer FP
    PLoS One; 2018; 13(4):e0195757. PubMed ID: 29649276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection.
    Correa L; Martino MD; Siqueira I; Pasternak J; Gales AC; Silva CV; Camargo TZ; Scherer PF; Marra AR
    BMC Infect Dis; 2013 Feb; 13():80. PubMed ID: 23398691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018.
    Lee YL; Lu MC; Shao PL; Lu PL; Chen YH; Cheng SH; Ko WC; Lin CY; Wu TS; Yen MY; Wang LS; Liu CP; Lee WS; Shi ZY; Chen YS; Wang FD; Tseng SH; Lin CN; Chen YH; Sheng WH; Lee CM; Liao MH; Hsueh PR
    Int J Antimicrob Agents; 2019 Sep; 54(3):318-328. PubMed ID: 31202925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining the burden of infectious diseases caused by carbapenem-resistant gram-negative bacteria in Spain.
    Cantón R; Huarte R; Morata L; Trillo-Mata JL; Muñoz R; González J; Tort M; Badia X
    Enferm Infecc Microbiol Clin (Engl Ed); 2021 Apr; 39(4):179-183. PubMed ID: 32576392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of carbapenem resistant gram-negative bacilli from infected pediatric population in tertiary - care hospitals in Medellín, Colombia: an increasing problem.
    Vanegas JM; Parra OL; Jiménez JN
    BMC Infect Dis; 2016 Sep; 16(1):463. PubMed ID: 27585707
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Wang C; Zhao J; Liu Z; Sun A; Sun L; Li B; Lu B; Liu Y; Cao B
    Front Microbiol; 2021; 12():727946. PubMed ID: 34630354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of carbapenem-resistant
    Yan WJ; Jing N; Wang SM; Xu JH; Yuan YH; Zhang Q; Li AL; Chen LH; Zhang JF; Ma B; Ma Q; Li Y
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33587030
    [No Abstract]   [Full Text] [Related]  

  • 18. High Carbapenem Resistance in Clinical Gram-Negative Pathogens Isolated in Egypt.
    Khalifa HO; Soliman AM; Ahmed AM; Shimamoto T; Hara T; Ikeda M; Kuroo Y; Kayama S; Sugai M; Shimamoto T
    Microb Drug Resist; 2017 Oct; 23(7):838-844. PubMed ID: 28191865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Epidemiology of Carbapenem- and Colistin-Resistant
    Palmieri M; D'Andrea MM; Pelegrin AC; Mirande C; Brkic S; Cirkovic I; Goossens H; Rossolini GM; van Belkum A
    Front Microbiol; 2020; 11():294. PubMed ID: 32153554
    [No Abstract]   [Full Text] [Related]  

  • 20. Transmission Dynamics of Carbapenem-Resistant
    Kong Y; Sun Q; Chen H; Draz MS; Xie X; Zhang J; Ruan Z
    Front Microbiol; 2021; 12():736896. PubMed ID: 34690977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.